Clinical Trial Results: Rifaximin in Patients With Diabetic Gastroparesis [Phase 2]

View source ↗

Summary

Phase 2 trial results for rifaximin in diabetic gastroparesis are reported (terminated; results posted).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Diabetic Gastroparesis

Drugs mentioned

• Rifaximin (rifaximin)

Snippet

Sponsor: Mayo Clinic | Conditions: Crohn Disease, Diabetic Gastroparesis | Phase 2 | Status: TERMINATED | Results posted: 2026-06-22